Diodenlaser-Zyklophotokoagulation in der Behandlung therapierefraktärer Glaukome

Abstract

This study suggests that contact diode laser cyclophotocoagulation is an effective method and a valid alternative to cyclocryocoagulation in the treatment of refractory glaucoma including congenital glaucoma.

Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma

“…The success rate in this study was 36.7% after 24 months. These results are comparable with the data of other authors in primary open-angle glaucoma and pseudoexfoliative glaucoma [2,3,8,9,12,[15][16][17][18][20][21][22]. For primary open-angle glaucoma success rates range from 75 to 90% after 1 year [12,13,16,21].…”

“…This is due to a lower preoperative IOP (median: 21 mmHg; 5-95% quantile: 12-36 mmHg) compared with 32 mmHg up to 42 mmHg in other reports [2,3,8,9,12,[15][16][17][18][20][21][22]. Studies with comparable preoperative IOP values showed comparable IOP reductions [13,19].…”

“…While immediate complications are transitory, late complications, such as phthisis and bulbus hypotonia, are rare [2,6,16]. TDLC has been used successfully in the treatment of refractive glaucoma with an overall success rate of between 35 and 85% [2,3,8,9,12,[15][16][17][18][20][21][22]. Although it has been proposed several times, reports of TDLC as a primary surgical treatment are rare and inconsistent [1,5,10,13].…”

Cyclophotocoagulation and cyclocryocoagulation as primary surgical procedures for open-angle glaucoma

“…According to the guidelines published by the European Glaucoma Society (EGS), however, CPC should be used only if a filtering procedure is likely to fail or has already failed [5]. Transscleral diode laser cyclophotocoagulation has been used successfully in the treatment of refractory glaucoma, with an overall success rate of between 35 and 85 % [6][7][8][9][10][11][12][13][14][15][16][17]. Although CCT is no longer recommended by the EGS [5], the data pool available to date on the use of both CPC [18][19][20][21][22] and CCT [23,24] as primary therapy in patients with open-angle glaucoma cannot be regarded as extensive.…”

Alteration of the vascular supply in the rabbit ciliary body by transscleral diode laser cyclophotocoagulation

“…In general, the procedure is reserved for patients with advanced (often secondary) glaucoma, which is refractory to medical or other surgical treatment [10]. In heterogeneous glaucoma populations overall success rates between 35% and 85% were reported [1,2,11,16,21,22,25,27]. The incidence of side effects seems to be significantly lower with contact diode laser cyclophotocoagulation than with other cyclodestructive procedures (cyclocryocoagulation, non-contact Nd:YAG laser cyclophotocoagulation).…”